<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38097988</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.</ArticleTitle><Pagination><StartPage>877</StartPage><MedlinePgn>877</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">877</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08898-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent headache is a frequent symptom after coronavirus disease 2019 (COVID-19) and there is currently limited knowledge about its clinical spectrum and predisposing factors. A subset of patients may be experiencing new daily persistent headache (NDPH) after COVID-19, which is among the most treatment-refractory primary headache syndromes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a cross-sectional study in Latin America to characterize individuals with persistent headache after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to identify factors associated with NDPH. Participants over 18 years old who tested positive for SARS-CoV-2 infection and reported persistent headache among their symptoms completed an online survey that included demographics, past medical history, persistent headache clinical characteristics, and COVID-19 vaccination status. Based on participants' responses, NDPH diagnostic criteria were used to group participants into NDPH and non-NDPH groups. Participant data was summarized by descriptive statistics. Student's t and Mann-Whitney U tests were used according to the distribution of quantitative variables. For categorical variables, Pearson's chi-square and Fisher's exact tests were used according to the size of expected frequencies. Binomial logistic regression using the backward stepwise selection method was performed to identify factors associated with NDPH.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four hundred and twenty-one participants from 11 Latin American countries met the inclusion criteria. One in four participants met the NDPH diagnostic criteria. The mean age was 40 years, with most participants being female (82%). Over 90% of the participants reported having had mild/moderate COVID-19. Most participants had a history of headache before developing COVID-19 (58%), mainly migraine type (32%). The most predominant clinical characteristics in the NDPH group were occipital location, severe/unbearable intensity, burning character, and radiating pain (p&#x2009;&lt;&#x2009;0.05). A higher proportion of anxiety symptoms, sleep problems, myalgia, mental fog, paresthesia, nausea, sweating of the face or forehead, and ageusia or hypogeusia as concomitant symptoms were reported in participants with NDPH (p&#x2009;&lt;&#x2009;0.05). Palpebral edema as a concomitant symptom during the acute phase of COVID-19, occipital location, and burning character of the headache were risk factors associated with NDPH.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This is the first study in Latin America that explored the clinical spectrum of NDPH after SARS-CoV-2 infection and its associated factors. Clinical evaluation of COVID-19 patients presenting with persistent headache should take into consideration NDPH.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carri&#xf3;n-Nessi</LastName><ForeName>Fhabi&#xe1;n S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Luis Razetti" School of Medicine, Central University of Venezuela, Caracas, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascanio</LastName><ForeName>Luis C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pineda-Arap&#xe9;</LastName><ForeName>Andre&#xed;na G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oma&#xf1;a-&#xc1;vila</LastName><ForeName>&#xd3;scar D</ForeName><Initials>&#xd3;D</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Luis Razetti" School of Medicine, Central University of Venezuela, Caracas, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendoza-Mill&#xe1;n</LastName><ForeName>Daniela L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Luis Razetti" School of Medicine, Central University of Venezuela, Caracas, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Sinibaldo R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Scientist Training Program (MD/PhD), University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almao-Rivero</LastName><ForeName>Abranny B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camejo-&#xc1;vila</LastName><ForeName>Natasha A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebran-Chedid</LastName><ForeName>Karim J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Saavedra</LastName><ForeName>Carlis M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freitas-De Nobrega</LastName><ForeName>Diana C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casta&#xf1;eda</LastName><ForeName>Sergio A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Centro de Investigaciones en Microbiolog&#xed;a y Biotecnolog&#xed;a, Facultad de Ciencias Naturales, Universidad del Rosario (CIMBIUR), Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forero-Pe&#xf1;a</LastName><ForeName>Jos&#xe9; L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Noguera</LastName><ForeName>Lourdes A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneses-Ram&#xed;rez</LastName><ForeName>Lucianny K</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>"Dr. Francisco Battistini Casalta" Health Sciences School, University of Oriente - Bolivar Nucleus, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotu&#xe1;</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Morales</LastName><ForeName>Alfonso J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Master of Clinical Epidemiology and Biostatistics, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forero-Pe&#xf1;a</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela. vacter.cv@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela. vacter.cv@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Luis Razetti" School of Medicine, Central University of Venezuela, Caracas, Venezuela. vacter.cv@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Department, University Hospital of Caracas, Caracas, Venezuela. vacter.cv@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paniz-Mondolfi</LastName><ForeName>Alberto E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Venezuelan Science Incubator, Barquisimeto, Venezuela. alberto.paniz-mondolfi@mountsinai.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. alberto.paniz-mondolfi@mountsinai.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007843" MajorTopicYN="N" Type="Geographic">Latin America</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020773" MajorTopicYN="Y">Headache Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cross-sectional survey</Keyword><Keyword MajorTopicYN="N">Latin America</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">NDPH</Keyword><Keyword MajorTopicYN="N">New daily persistent headache</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>17</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>0</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38097988</ArticleId><ArticleId IdType="pmc">PMC10722794</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08898-2</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08898-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19.) Dashboard [https://covid19.who.int/].</Citation></Reference><Reference><Citation>Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 Infection. Brain Behav Immun. 2020;88:11&#x2013;6. doi: 10.1016/j.bbi.2020.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.037</ArticleId><ArticleId IdType="pmc">PMC7235586</ArticleId><ArticleId IdType="pubmed">32416289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus Pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507&#x2013;13. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;90. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Fern&#xe1;ndez-D&#xed;az E, S&#xe1;nchez-Larsen &#xc1;, Layos-Romero A, Garc&#xed;a-Garc&#xed;a J, Gonz&#xe1;lez E, Redondo-Pe&#xf1;as I, Perona-Moratalla AB, Del Valle-P&#xe9;rez JA, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060&#x2013;70. doi: 10.1212/WNL.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnazzo F, Arquizan C, Derraz I, Dargazanli C, Lefevre PH, Riquelme C, Gaillard N, Mourand I, Gascou G, Bonafe A, et al. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol. 2021;268(8):2656&#x2013;65. doi: 10.1007/s00415-020-10285-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10285-9</ArticleId><ArticleId IdType="pmc">PMC7597753</ArticleId><ArticleId IdType="pubmed">33125542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-COVID: cognitive deficits (brain fog) and brain lesions in non-hospitalized patients. Presse Med. 2022;51(2):104090. doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho SJ, Harriott AM, Garc&#xed;a-Azor&#xed;n D, Labastida-Ramirez A, Ornello R, Raffaelli B, Beltr&#xe1;n ER, Ruscheweyh R, et al. Long COVID headache. J Headache Pain. 2022;23(1):93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, Cuadrado ML, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L, Plaza-Manzano G. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820&#x2013;5. doi: 10.1111/ene.15040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V, Cuadrado ML, Palacios-Ce&#xf1;a D, Florencio LL, Guerrero AL, Garc&#xed;a-Azor&#xed;n D, Hern&#xe1;ndez-Barrera V, Arendt-Nielsen L. The presence of headache at onset in SARS-CoV-2 Infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021;41(13):1332&#x2013;41. doi: 10.1177/03331024211020404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211020404</ArticleId><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Ballv&#xe9; A, Llaurad&#xf3; A, Gallardo VJ, Ariton DM, Lallana S, L&#xf3;pez Maza S, Oliv&#xe9; Gadea M, Quibus L, Restrepo JL, et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40(13):1410&#x2013;21. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho PA, Voss L. Persistent headache and persistent Anosmia Associated with COVID-19. Headache. 2020;60(8):1797&#x2013;9. doi: 10.1111/head.13941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13941</ArticleId><ArticleId IdType="pmc">PMC7436496</ArticleId><ArticleId IdType="pubmed">32790179</ArticleId></ArticleIdList></Reference><Reference><Citation>Dearing L, M&#xfc;ller F, Sellner J. Headache with SARS-CoV-2 Infection: A matter of concern. Eur J Neurol. 2021;28(11):3554&#x2013;5. doi: 10.1111/ene.15084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15084</ArticleId><ArticleId IdType="pmc">PMC8653277</ArticleId><ArticleId IdType="pubmed">34437746</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: three migraine-like yet distinct scenarios. Headache. 2021;61(8):1277&#x2013;80. doi: 10.1111/head.14197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Dono F, Consoli S, Evangelista G, D&#x2019;Apolito M, Russo M, Carrarini C, Calisi D, De Rosa M, Di Pietro M, De Angelis MV, et al. New daily persistent headache after SARS-CoV-2 Infection: a report of two cases. Neurol Sci. 2021;42(10):3965&#x2013;8. doi: 10.1007/s10072-021-05444-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05444-3</ArticleId><ArticleId IdType="pmc">PMC8280630</ArticleId><ArticleId IdType="pubmed">34264414</ArticleId></ArticleIdList></Reference><Reference><Citation>Headache Classification Committee of the International Headache Society (IHS) The International classification of Headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1&#x2013;211. doi: 10.1177/0333102417738202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102417738202</ArticleId><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozen TD. Daily persistent headache after a viral Illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian/Asiatic Flu. Cephalalgia. 2020;40(13):1406&#x2013;9. doi: 10.1177/0333102420965132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965132</ArticleId><ArticleId IdType="pmc">PMC7645599</ArticleId><ArticleId IdType="pubmed">33146034</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons AC, Bonner A, Giel A, Pezzano A, Rothner AD. Probable New Daily Persistent Headache after COVID-19 in children and adolescents. Pediatr Neurol. 2022;132:1&#x2013;3. doi: 10.1016/j.pediatrneurol.2022.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9045862</ArticleId><ArticleId IdType="pubmed">35598584</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, Lapa J, Braga LM, Almeida MM, Cunha P, et al. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur J Pain. 2021;25(6):1342&#x2013;54. doi: 10.1002/ejp.1755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>. In: Coronavirus Disease 2019 (COVID-19) treatment guidelines. edn. Bethesda (MD): National Institutes of Health (US); 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID. [https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Some%20people%2C%20especially%20those%20who,kidney%2C%20skin%2C%20and%20brain].</Citation></Reference><Reference><Citation>PAHO/WHO: PAHO Weekly COVID-19 Epidemiological Update &#x2013;&#x2009;12 April 2022. In., vol. 2022. Washington, D.C.: Pan American Health Organization/World Health Organization; 2022.</Citation></Reference><Reference><Citation>Vanast W. New daily persistent headache: definition of a benign syndrome. Headache. 1986;26:317.</Citation></Reference><Reference><Citation>Evans RW, Turner DP. Clinical features of new daily persistent headache: a retrospective chart review of 328 cases. Headache. 2021;61(10):1529&#x2013;38. doi: 10.1111/head.14207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14207</ArticleId><ArticleId IdType="pubmed">34710236</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozen TD. Triggering events and New Daily Persistent Headache: age and gender differences and insights on Pathogenesis-A clinic-based study. Headache. 2016;56(1):164&#x2013;73. doi: 10.1111/head.12707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.12707</ArticleId><ArticleId IdType="pubmed">26474179</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010;74(17):1358&#x2013;64. doi: 10.1212/WNL.0b013e3181dad5de.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181dad5de</ArticleId><ArticleId IdType="pmc">PMC3462554</ArticleId><ArticleId IdType="pubmed">20421580</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo J, Mu&#xf1;oz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999;39(3):190&#x2013;6. doi: 10.1046/j.1526-4610.1999.3903190.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-4610.1999.3903190.x</ArticleId><ArticleId IdType="pubmed">15613213</ArticleId></ArticleIdList></Reference><Reference><Citation>Grande RB, Aaseth K, Lundqvist C, Russell MB. Prevalence of new daily persistent headache in the general population. The Akershus Study of Chronic Headache Cephalalgia. 2009;29(11):1149&#x2013;55. doi: 10.1111/j.1468-2982.2009.01842.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-2982.2009.01842.x</ArticleId><ArticleId IdType="pubmed">19830882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigal ME, Lipton RB, Tepper SJ, Rapoport AM, Sheftell FD. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology. 2004;63(5):843&#x2013;7. doi: 10.1212/01.WNL.0000137039.08724.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000137039.08724.18</ArticleId><ArticleId IdType="pubmed">15365134</ArticleId></ArticleIdList></Reference><Reference><Citation>Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug-based treatment, and prognosis of new daily persistent headache (NDPH): 30 cases in Japan. Cephalalgia. 2004;24(11):955&#x2013;9. doi: 10.1111/j.1468-2982.2004.00771.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-2982.2004.00771.x</ArticleId><ArticleId IdType="pubmed">15482358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung E, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. New daily persistent headache in the paediatric population. Cephalalgia. 2009;29(1):17&#x2013;22. doi: 10.1111/j.1468-2982.2008.01647.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-2982.2008.01647.x</ArticleId><ArticleId IdType="pubmed">19126116</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamani N, Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. J Headache Pain. 2019;20(1):80. doi: 10.1186/s10194-019-1022-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-019-1022-z</ArticleId><ArticleId IdType="pmc">PMC6734284</ArticleId><ArticleId IdType="pubmed">31307396</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng KP, Fuh JL, Yuan HK, Shia BC, Wang SJ. New daily persistent headache: should migrainous features be incorporated? Cephalalgia. 2011;31(15):1561&#x2013;9. doi: 10.1177/0333102411424620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102411424620</ArticleId><ArticleId IdType="pubmed">21960650</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Mitoma F, Vanast WJ, Tyrrell DL. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet. 1987;1(8530):411&#x2013;5. doi: 10.1016/S0140-6736(87)90119-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(87)90119-X</ArticleId><ArticleId IdType="pubmed">2880216</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez JT, Garc&#xed;a-Azor&#xed;n D, Planchuelo-G&#xf3;mez &#xc1;, Garc&#xed;a-Iglesias C, Due&#xf1;as-Guti&#xe9;rrez C, Guerrero &#xc1;L. Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020;40(13):1432&#x2013;42. doi: 10.1177/0333102420965146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965146</ArticleId><ArticleId IdType="pmc">PMC7645601</ArticleId><ArticleId IdType="pubmed">33146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrente A, Alonge P, Di Stefano V, Baschi R, Ornello R, Correnti E, Lupica A, Camarda C, Farinella G, Raieli V, et al. New-onset headache following COVID-19: an Italian multicentre case series. J Neurol Sci. 2023;446:120591. doi: 10.1016/j.jns.2023.120591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2023.120591</ArticleId><ArticleId IdType="pmc">PMC9931424</ArticleId><ArticleId IdType="pubmed">36807975</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash S, Saini S, Rana KR, Mahato P. Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India. J Headache Pain. 2012;13(6):477&#x2013;85. doi: 10.1007/s10194-012-0461-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10194-012-0461-6</ArticleId><ArticleId IdType="pmc">PMC3464463</ArticleId><ArticleId IdType="pubmed">22644215</ArticleId></ArticleIdList></Reference><Reference><Citation>Meineri P, Torre E, Rota E, Grasso E. New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci. 2004;25(Suppl 3):281&#x2013;2. doi: 10.1007/s10072-004-0310-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-004-0310-8</ArticleId><ArticleId IdType="pubmed">15549561</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22(1):66&#x2013;9. doi: 10.1046/j.1468-2982.2002.00326.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-2982.2002.00326.x</ArticleId><ArticleId IdType="pubmed">11993616</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho SM. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 2023, 12(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo S-S, Chen W, Jung KL, Azamor T, Choi UY, Zhang P, Comhair SA, Erzurum SC, Jehi L, Jung JU. Immunometabolic rewiring in long COVID patients with chronic headache. 2023:2023.2003.2006.531302.</Citation></Reference><Reference><Citation>World Health O. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. In. Geneva: World Health Organization; 2021.</Citation></Reference><Reference><Citation>Strong E, Pierce EL, Langdon R, Strelzik J, McClintock W, Cameron M, Furda M, DiSabella M. New Daily Persistent Headache in a Pediatric Population. J Child Neurol. 2021;36(10):888&#x2013;93. doi: 10.1177/08830738211004514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08830738211004514</ArticleId><ArticleId IdType="pubmed">34048280</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Cuadrado ML, G&#xf3;mez-Mayordomo V, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 variant. Expert Rev Neurother. 2023;23(2):179&#x2013;86. doi: 10.1080/14737175.2023.2185138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2023.2185138</ArticleId><ArticleId IdType="pubmed">36857191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema S, Matharu M. Cluster headache: what&#x2019;s New? Neurol India. 2021;69(Supplement):124&#x2013;s134.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003158</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. 2021;96(4):e575&#x2013;86. doi: 10.1212/WNL.0000000000010979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010979</ArticleId><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Cho YJ, Lee SY. Neurological manifestations in patients with COVID-19: experiences from the Central Infectious Diseases Hospital in South Korea. J Clin Neurol (Seoul Korea) 2021;17(3):435&#x2013;42. doi: 10.3988/jcn.2021.17.3.435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2021.17.3.435</ArticleId><ArticleId IdType="pmc">PMC8242315</ArticleId><ArticleId IdType="pubmed">34184452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases. (London England) 2021;53(10):737&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92(7):699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Veleri S. Neurotropism of SARS-CoV-2 and neurological Diseases of the central nervous system in COVID-19 patients. Exp Brain Res. 2022;240(1):9&#x2013;25. doi: 10.1007/s00221-021-06244-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-021-06244-z</ArticleId><ArticleId IdType="pmc">PMC8543422</ArticleId><ArticleId IdType="pubmed">34694467</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021, 218(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573&#x2013;80. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine J, Schwichtenberg K, Hartung TJ, Rekers S, Chien C, Boesl F, Rust R, Hohenfeld C, Bungenberg J, Costa AS, et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. EClinicalMedicine. 2023;58:101874. doi: 10.1016/j.eclinm.2023.101874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101874</ArticleId><ArticleId IdType="pmc">PMC9969172</ArticleId><ArticleId IdType="pubmed">36873426</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor FR. Tobacco, Nicotine, and Headache. Headache. 2015;55(7):1028&#x2013;44. doi: 10.1111/head.12620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.12620</ArticleId><ArticleId IdType="pubmed">26140522</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng KP, Rozen TD. Update in the understanding of new daily persistent headache. Cephalalgia. 2023;43(2):3331024221146314. doi: 10.1177/03331024221146314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024221146314</ArticleId><ArticleId IdType="pubmed">36759317</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia. 2008;28(6):626&#x2013;30. doi: 10.1111/j.1468-2982.2008.01565.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-2982.2008.01565.x</ArticleId><ArticleId IdType="pubmed">18422722</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D, Trigo J, Talavera B, Mart&#xed;nez-P&#xed;as E, Sierra &#xc1;, Porta-Etessam J, Arenillas JF, Guerrero &#xc1;L. Frequency and type of red flags in patients with Covid-19 and headache: a Series of 104 hospitalized patients. Headache. 2020;60(8):1664&#x2013;72. doi: 10.1111/head.13927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13927</ArticleId><ArticleId IdType="pmc">PMC7436570</ArticleId><ArticleId IdType="pubmed">32790215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema S, Stubberud A, Rantell K, Nachev P, Tronvik E, Matharu M. Phenotype of new daily persistent headache: subtypes and comparison to transformed chronic daily headache. J Headache Pain. 2023;24(1):109. doi: 10.1186/s10194-023-01639-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-023-01639-5</ArticleId><ArticleId IdType="pmc">PMC10428606</ArticleId><ArticleId IdType="pubmed">37587430</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, Mencia &#xc1;S, Segura T, Gonzalez-Garc&#xed;a N, D&#xed;az-de-Ter&#xe1;n J, et al. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022;42(8):804&#x2013;9. doi: 10.1177/03331024211068074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211068074</ArticleId><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Uniyal R, Paliwal VK, Tripathi A. Psychiatric comorbidity in new daily persistent headache: a cross-sectional study. Eur J Pain. 2017;21(6):1031&#x2013;8. doi: 10.1002/ejp.1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1000</ArticleId><ArticleId IdType="pubmed">28146324</ArticleId></ArticleIdList></Reference><Reference><Citation>Reidy BL, Riddle EJ, Powers SW, Slater SK, Kacperski J, Kabbouche MA, Hershey AD. Clinic-based characterization of continuous headache in children and adolescents: comparing youth with chronic migraine to those with new daily persistent headache. Cephalalgia. 2020;40(10):1063&#x2013;9. doi: 10.1177/0333102420920644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420920644</ArticleId><ArticleId IdType="pubmed">32336121</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>